Germany’s nova-Institute has released a report on CBD production technologies, medical applications and the EU regulatory framework for cannabinoids. The 142-page report discusses established and emerging biotechnological approaches to the production of cannabinoids, and gives an overview of state-of-the-art production methods for plant extraction and chemical synthesis. Aimed at pharmaceutical and biotech industry professionals, the report was written by nova-Institute authors Dr. Pia Skoczinski; Dr. med. Franjo Grotenhermen; and Dr. rer. nat. Bernhard Beitzke, a chemist who is a long-time adviser to the European Industrial Hemp Association.
Like HempToday? How you can support us
Your donations help us to keep HempToday open for all readers, regardless of what they can afford to pay. Through this “information equality” we're able to support hemp entrepreneurs and stakeholders all over the world by keeping a spotlight on hemp and all the promise it offers for economic development and healing our planet.